UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Passive income strategies can provide financial stability. Learn how to use index funds to create a reliable income stream.
21,140 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
MortgageOne TPO announces an ARIVE integration alongside the Pathway CDFI loan program, aiming to broaden homeownersh...
As Endava enters the back half of 2026, the Q3 earnings narrative centers on margin discipline, cloud-led growth, and...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...
SpaceX has filed for a $75 billion IPO valuing the company at about $1.75 trillion, signaling a watershed moment for ...
Ford just revealed a bold $2 billion energy push designed to power AI data centers. This article breaks down what the...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Investors weigh Oxford Industries' next moves as oxford (oxm) 2025 earnings hinge on tariff costs, brand mix, and a b...
When a major tech supplier delivers a standout quarter, investors take notice. This article explains why hewlett pack...
The ripple (xrp) price down narrative dominates crypto desks as XRP slides toward $1 amid a market-wide pullback. Her...
A formerly troubled telehealth stock is catching fresh attention from investors. This article explores the bull case,...